Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2500 (LINC02500)

Target
LINC02500
Molecular classification
Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 2500 (LINC02500) is a human long intergenic non-coding RNA (lincRNA) gene. The primary feature of this molecule is that it does not encode a protein, but may have regulatory functions related to gene expression and chromatin architecture, which are general functions documented for lincRNAs[5]. LINC02500 is located at 4q34.3 and has been identified as a region recurrently deleted in several cancer types, especially in cervical and endometrial cancers, suggesting a putative tumor suppressor role[4]. While the biological function of LINC02500 is currently not well characterized, recent research highlights its possible involvement in cancer pathogenesis. There is no evidence of drug interaction, approved therapeutic targeting, or detailed mechanism of action at present. It is not considered a therapeutic target (receptor, enzyme, transporter, etc.) in current biomedical literature[4][1].

02

Biological functions

Regulation of gene expression (by analogy with the class of lincRNAs)Chromatin remodeling (general lincRNA function)Potential tumor suppressor function in cancer (suggested)
03

Disease associations

Cancer (multiple cancers, especially cervical and endometrial carcinoma, as a recurrent deleted region and possible tumor suppressor)
04

Biomarkers

Possible biomarker for cervical cancer risk (as a deleted region)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2500 (LINC02500).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2500 (LINC02500).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call